Schrettl, P., Ilieva, N., Tashkova, D. Early HER2-positive breast cancer with complete pathologic response to neoadjuvant therapy: a case series. Plovdiv: 2022 7-11,.
Schrettl, P., Ilieva, N., Tashkova, D. Early HER2-positive breast cancer with complete pathologic response to neoadjuvant therapy: a case series. Plovdiv: 2022 7-11,.
Schrettl, P., Ilieva, N., Tashkova, D. (2022) Early HER2-positive breast cancer with complete pathologic response to neoadjuvant therapy: a case series, Plovdiv: 7-11,.
Schrettl, P., Ilieva, N., & Tashkova, D. (2022). Early HER2-positive breast cancer with complete pathologic response to neoadjuvant therapy: a case series. Plovdiv: 7-11.
Schrettl P, Ilieva N, Tashkova D. Early HER2-positive breast cancer with complete pathologic response to neoadjuvant therapy: a case series. Plovdiv: 2022. p. 7-11.